Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.
about
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trialQuantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosisRare coding variants in the phospholipase D3 gene confer risk for Alzheimer's diseaseGene expression parallels synaptic excitability and plasticity changes in Alzheimer's diseaseCommon defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploringReevaluating Metabolism in Alzheimer's Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle ModelMitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionAlzheimer's pathogenesis and its link to the mitochondrionNew cellular and molecular approaches to ageing brainHuman wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins.S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegenerationConnectivity Disruption, Atrophy, and Hypometabolism within Posterior Cingulate Networks in Alzheimer's DiseaseA chaperome subnetwork safeguards proteostasis in aging and neurodegenerative diseaseEnergy failure: does it contribute to neurodegeneration?DEGAS: de novo discovery of dysregulated pathways in human diseasesUsing bioconductor package BiGGR for metabolic flux estimation based on gene expression changes in brainA computational procedure for functional characterization of potential marker genes from molecular data: Alzheimer's as a case studyAge-correlated gene expression in normal and neurodegenerative human brain tissuesAlzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genesLocus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains.Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study.AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and NeuronsCo-expression network-based analysis of hippocampal expression data associated with Alzheimer's disease using a novel algorithm.Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease.Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.ATP5H/KCTD2 locus is associated with Alzheimer's disease risk.Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brainsA Novel Method to Identify Differential Pathways in Hippocampus Alzheimer's DiseaseBrain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burdenA molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease, Glioblastoma and Lung cancerDeregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease.Selective neuronal vulnerability to oxidative stress in the brain.Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect.Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.Gene expression in the rodent brain is associated with its regional connectivity.Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease.
P2860
Q21245063-02C2163A-FE4D-4C65-865C-3861424432D3Q24297593-5F6D35A8-4BC3-4687-85CF-31448860290DQ24312938-3B597896-36E7-4B36-875D-E8C8A76D468AQ26785375-62650890-C247-4BD5-9F32-41D6AC77AC59Q26861082-2FC8219B-7C0B-41AB-9864-8F7CBFBBFDBBQ26864926-A40BE444-24BC-436C-83C3-A70799E607CCQ26865358-DB801F9A-6328-4883-B6FF-3E940B67C714Q27000255-234D289F-2A71-4C6C-88EC-75ACF35BA112Q27003450-AD247871-2077-448C-AFC4-51F3C7607B74Q27320038-0C949AE2-01C4-4890-8236-20996708E254Q27694603-42E9FADB-846C-45D4-A65F-2C70AE79D151Q28146452-BD001186-D8DA-4307-A7A7-0A8E3303D92AQ28252463-5C3A6449-6FE8-448C-B046-DFE30E0AD71CQ28389950-6A28DDD9-5EF7-4E03-9F58-A142CDE7CC1BQ28475850-6668F768-91B4-4A9C-BEC4-574854844CF8Q28544995-05769451-643E-49CD-8C2D-14F5F675FC5EQ28741856-7C03A4EE-770E-4CF0-81FC-7E705F62D380Q28749094-155F33AE-691A-429A-9A80-9D2579005AA3Q30360286-272E6AEE-FB54-4C25-B1BC-9F49A05F78D4Q30468815-007277DF-3E0E-4F7A-AE2E-2E6D752812C1Q30835713-43AD0A38-CD80-44EE-9D64-4AA86DFF00CBQ30882224-45353EE6-C049-464D-961E-80131A26B6C3Q31033689-78FBA54E-2E0F-46BB-8AA7-6DB766B38363Q31071777-F1C7C22C-AD54-4B8E-A550-37F6B5CDD1EBQ31095417-BEAB0C76-5ADE-476B-9981-4F905907C07DQ33364882-360A00D1-E2C2-42AE-9B71-8015BBEB3784Q33492748-FCDAAEB6-0DDD-4D73-BA5B-D2D22CEE5A7DQ33601299-AED44A59-3CF2-4340-B5E3-32B19ACD3A80Q33652534-6FF67943-D9A8-4E2F-890B-0971FD4CA023Q33692288-72D06A7B-A624-4A2C-947D-D6BDE917DEFFQ33702839-F7AC0BB7-A8F4-4D70-8675-02F065C6692EQ33792226-E33F2E9B-450B-4439-9206-AEBE02B97174Q33803956-D849154E-85B0-4E6B-B19E-664C8440DCE4Q33860823-AE1B9BA3-BA57-4347-8BF6-1A6CD3B611AEQ33862808-BF2B98FA-5B2F-4576-85F7-83154CE8972EQ33868370-F92568C9-0E3F-4CFB-8139-BDA77C38B397Q33889224-D8710DD7-DF59-4700-A576-143AFF72CFFCQ33897771-F064E11E-D18D-4CE1-8B91-15947C4CE3C7Q33900841-C5403FD4-39FD-43A4-958A-615D2EDB2B43Q34002680-C736B685-57F7-4278-860B-3A5305460626
P2860
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@ast
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@en
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@nl
type
label
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@ast
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@en
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@nl
prefLabel
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@ast
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@en
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@nl
P2093
P2860
P50
P356
P1476
Alzheimer's disease is associa ...... n posterior cingulate neurons.
@en
P2093
Andrew Grover
Christine M Hulette
Diego Mastroeni
Dietrich A Stephan
Donald Schmechel
Joseph Rogers
Lonnie E Schneider
Richard Caselli
Tracey L Niedzielko
P2860
P304
P356
10.1073/PNAS.0709259105
P407
P577
2008-03-10T00:00:00Z